7q11.23 duplication syndrome
A rare genetic syndrome from duplication of chromosome 7q11.23.
7q11.23 duplication syndrome, also known as dup7 or 7dup, is a rare genetic condition first identified in 2005. It arises from an extra copy of a roughly 1.5 to 1.8 megabase segment on the long arm of chromosome 7, within the Williams-Beuren syndrome critical region (WBSCR). The syndrome presents with a mix of neurological, behavioral, and medical issues that range widely in severity. Common features include delays in speech and language, low muscle tone (hypotonia), anxiety disorders, selective mutism, attention-deficit/hyperactivity disorder (ADHD), oppositional defiant disorder, autism spectrum disorder, intellectual disability, and enlargement of the ascending aorta.
Diagnosis is confirmed through chromosomal microarray analysis, which detects the duplication. There is no cure; management focuses on speech and language therapy, behavioral interventions, and addressing medical complications like aortic dilation and seizures. The condition is estimated to affect 1 in 7,500 to 1 in 20,000 people, though it is believed to be underdiagnosed.
**Signs and Symptoms**
**Neurological** - Involuntary movements, such as mirror movements on one side of the body that copy intentional movements on the other, occur in 83% of cases. - Delayed motor development and coordination difficulties (developmental coordination disorder) affect 74.2%. - Low muscle tone (hypotonia) is present in 58.5%, impacting posture, movement, and milestones like sitting and walking. - Seizures or epilepsy are seen in 19%. - Hydrocephalus, a buildup of fluid in brain cavities that can raise pressure, occurs in 5.6%.
**Speech and Language** - Speech sound disorders, including childhood apraxia of speech (trouble planning and coordinating speech muscles) and dysarthria (weak or poorly controlled speech muscles), affect 82.6%. - Speech and language development is delayed, with expressive language (speaking) typically more affected than receptive language (understanding).
**Behavioral** - Anxiety disorders, especially social anxiety and specific phobias (e.g., fear of medical visits), are common; at least 60% meet criteria for one or more anxiety disorders. - ADHD, involving inattention, hyperactivity, and impulsivity, is found in 35.5%. - Selective mutism, an inability to speak in certain settings (like school) despite speaking elsewhere, occurs in 29%. - Oppositional defiant disorder (ODD), a
- first_reported
- 2005
- prevalence
- 1 in 7,500 to 1 in 20,000
- inheritance
- Autosomal dominant
- de_novo_cases
- 73%
- inherited_cases
- 27%
- key_gene_region
- WBSCR (26-28 genes)
- associated_condition
- Williams syndrome (deletion of same region)
Lore & Background
7q11.23 duplication syndrome results from an extra copy of a region on chromosome 7 that is susceptible to chromosomal rearrangements due to flanking segmental duplications. While deletion of this region causes Williams syndrome, duplication leads to contrasting features: individuals with Williams syndrome tend to be socially outgoing, while those with 7q11.23 duplication syndrome tend to be socially anxious. Similarly, deletion leads to narrowing of the ascending aorta, while duplication leads to dilation of the ascending aorta. Several genes within the duplicated region are thought to contribute to specific features; an extra copy of the ELN gene is likely related to aortic dilation, and an extra copy of the GTF2I gene is associated with behavioral features including social anxiety.
Reader's Guide
7q11.23 duplication syndrome is significant as a rare genetic disorder that highlights the contrasting effects of copy number variations in the same chromosomal region. Its diagnosis is established by chromosomal microarray analysis detecting the duplication, and there is no cure; treatment focuses on speech and language therapy, behavioral interventions, and management of medical complications such as aortic dilation and seizures. The syndrome is considered underdiagnosed, with prevalence estimated at 1 in 7,500 to 1 in 20,000. The condition's variable severity and wide range of features—from speech sound disorders and anxiety to aortic dilation—underscore the importance of comprehensive evaluations including echocardiography, developmental assessments, and behavioral therapy. Understanding the syndrome's genetic basis, particularly the roles of ELN and GTF2I, may inform future research into targeted treatments.
Did You Know?
- About 73% of cases arise as a new (de novo) genetic change not inherited from either parent.
- Individuals with the syndrome have a 46% prevalence of dilation of the ascending aorta.
- Chronic constipation is a significant problem in 66% of children and 27% of adults with the syndrome.
- The syndrome was first reported in 2005.
Genetic Architecture and the Williams-Beuren Mirror
The 7q11.23 duplication syndrome, first described in the medical literature in 2005, arises when an individual carries an extra copy of roughly 1.5 to 1.8 megabases of DNA on the long arm of chromosome 7. This stretch, known as the Williams-Beuren syndrome critical region, houses approximately 26 to 28 genes and sits between two stretches of repetitive DNA called segmental duplications, which make the area prone to mis-segregation during cell division. What makes the genetics particularly striking is the near-mirror relationship to Williams syndrome: losing this same region produces Williams syndrome, while gaining an extra copy produces 7dup. The clinical contrast is vivid. People with Williams syndrome are typically socially effusive, whereas those with the duplication tend toward social anxiety. Williams syndrome narrows the ascending aorta; the duplication dilates it. Researchers suspect the elastin-encoding ELN gene drives the vascular difference, while the transcription-factor gene GTF2I may underlie the behavioral profile, though the exact contribution of each gene to the full phenotype remains unresolved.
Neurological and Speech-Language Profile
The neurological footprint of 7dup is broad and often the first thing families notice. Involuntary movements, including mirror movements where one side of the body unconsciously imitates the other, appear in roughly 83 percent of affected individuals. Delayed motor milestones and coordination difficulties affect about three-quarters of those diagnosed, while low muscle tone—hypotonia—impairs posture, sitting, and walking in nearly 60 percent. Seizures and epilepsy occur in about 19 percent, and a smaller subset, around 5.6 percent, develop hydrocephalus, a buildup of cerebrospinal fluid that raises intracranial pressure. Speech and language challenges are nearly universal: 82.6 percent show a speech sound disorder, frequently childhood apraxia of speech or dysarthria, and expressive language typically lags well behind receptive language. Beyond the nervous system, chronic constipation is a persistent burden, troubling 66 percent of children and still 27 percent of adults, while recurring middle-ear infections affect a quarter of those affected.
Behavioral and Cardiovascular Landscape
The behavioral signature of 7q11.23 duplication syndrome is as varied as it is common. At least 60 percent of individuals meet criteria for one or more anxiety disorders, with social anxiety and specific phobias—such as intense fear of medical settings—being particularly prominent. ADHD is present in about 35.5 percent, and selective mutism, in which a child can speak at home but remains silent in school or other social contexts, affects roughly 29 percent. Oppositional defiant behavior, autism spectrum features (about 20 percent), and intellectual disability (approximately 18 percent, with another 20 percent at a borderline level) round out a complex behavioral picture. On the cardiovascular side, dilation of the ascending aorta is found in 46 percent of individuals and can progress over time, necessitating regular cardiac surveillance. Additional medical findings include strabismus in 15 percent, joint hypermobility, refractive errors requiring corrective lenses, hearing loss in 5 percent, and, in males, hypospadias. The wide variability means no two individuals present identically, complicating both recognition and long-term care planning.
Diagnosis, Inheritance, and the Path Forward
Because the clinical picture of 7dup is so heterogeneous, many affected individuals are never identified through symptoms alone. A clinician might suspect the condition when a child presents with delayed speech and motor development, childhood apraxia of speech, social anxiety, and selective mutism, but definitive confirmation requires chromosomal microarray analysis that detects the extra copy of the WBSCR segment. The syndrome follows an autosomal dominant inheritance pattern: a single extra copy is enough to produce the disorder. In roughly 73 percent of cases the duplication is de novo, arising spontaneously in the child. In the remaining 27 percent it is passed from a parent who may carry only subtle, previously undiagnosed signs. Each offspring of an affected parent faces a 50 percent chance of inheriting the duplication. No cure currently exists. Management is multidisciplinary, encompassing speech and language therapy, behavioral interventions for anxiety and ADHD, monitoring and treatment of aortic dilation, seizure management, and support for constipation and ear infections. With an estimated prevalence of one in 7,500 to one in 20,000, the syndrome remains underdiagnosed, and awareness among clinicians is still growing.
Frequently Asked Questions
Who is 7q11.23 duplication syndrome?
7q11.23 duplication syndrome (also called dup7 or 7dup) is a rare genetic condition first described in 2005, caused by an extra copy of roughly 1.5 to 1.8 megabases on the long arm of chromosome 7. It sits within the Williams-Beuren syndrome critical region, which spans about 26 to 28 genes.
What are 7q11.23 duplication syndrome's powers/role?
Rather than superpowers, this condition brings a wide spectrum of neurological and behavioral challenges, including speech and language delays, low muscle tone, anxiety, ADHD, oppositional defiant disorder, and features on the autism spectrum. Severity varies enormously from one individual to the next.
How does 7q11.23 duplication syndrome's story end?
There is no single ending; the condition is lifelong, and long-term outcomes depend heavily on how severe the initial presentation is. Many individuals benefit from early speech therapy, behavioral support, and ongoing medical monitoring of associated health issues.
Why is 7q11.23 duplication syndrome important?
It affects an estimated 1 in 7,500 to 1 in 20,000 people, making it rare but not unheard of. Because 73% of cases arise de novo (a new mutation rather than an inherited one), it can appear in families with no prior history, which makes genetic counseling especially critical.
How did 7q11.23 duplication syndrome come to be?
The syndrome follows an autosomal dominant inheritance pattern, yet the vast majority—about 73%—are new, spontaneous duplications rather than passed down from a parent. The remaining 27% are inherited from a carrier parent who may show milder or no symptoms.
More in Rare diseases 1-24
Spotted an error? Know more?
This is a living reference — every entry is fact-audited, and reader corrections feed straight into our audit queue. Suggest an edit · See this site's audit record
